11/05/2012, Glybera is a drug meant to fight a very rare disorder: Lipoprotein lipase deficiency ,(LPLD) which prevents patients from metabolizing certain fat enzymes in the blood . It does this by modifying a patient’s DNA, and the European Commission has approved it for public use and [...]
